Beneficial effects of bone marrow-derived mesenchymal stem cell transplantation in a non-immune model of demyelination
- 1 March 2015
- journal article
- Published by Elsevier in Annals of Anatomy - Anatomischer Anzeiger
- Vol. 198, 11-20
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Cell-Based Reparative Therapies for Multiple SclerosisCurrent Neurology and Neuroscience Reports, 2013
- Distribution of oligodendrocyte loss and mitochondrial toxicity in the cuprizone-induced experimental demyelination modelJournal of Neuroimmunology, 2013
- Abbreviated exposure to cuprizone is sufficient to induce demyelination and oligodendrocyte lossJournal of Neuroscience Research, 2012
- The Potential of Mesenchymal Stromal Cells as a Novel Cellular Therapy for Multiple SclerosisImmunotherapy, 2012
- Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis modelsNature Neuroscience, 2012
- Human bone marrow‐derived mesenchymal stem cells induce Th2‐polarized immune response and promote endogenous repair in animal models of multiple sclerosisGlia, 2009
- Isolation, Culture, and Differentiation Potential of Mouse Marrow Stromal CellsCurrent Protocols in Stem Cell Biology, 2008
- Multiple sclerosisThe Lancet, 2008
- Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesionAnnals of Neurology, 2004
- Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primatesBlood, 2003